| NDC Code | 68220-133-01 |
|---|
| Package Description | 3.785 L in 1 BOTTLE (68220-133-01) |
|---|
| Product NDC | 68220-133 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Colyte |
|---|
| Non-Proprietary Name | Polyethylene Glycol 3350, Sodium Chloride, Potassium Chloride, Sodium Bicarbonate, And Sodium Sulfate Anhydrous |
|---|
| Dosage Form | POWDER, FOR SOLUTION |
|---|
| Usage | NASOGASTRIC; ORAL |
|---|
| Start Marketing Date | 20100901 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA018983 |
|---|
| Manufacturer | Alaven Pharmaceutical LLC |
|---|
| Substance Name | POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE |
|---|
| Strength | 227.1; 5.53; 2.82; 6.36; 21.5 |
|---|
| Strength Unit | g/3.785L; g/3.785L; g/3.785L; g/3.785L; g/3.785L |
|---|
| Pharmacy Classes | Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
|---|